ODDB.org: Open Drug Database

GlaxoSmithKline AG - Xevudy, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	68471	Sequence	01
Product name	Xevudy	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	J06BD05	ATC-Description
Introduction of Sequence	14.01.2022

Composition

sotrovimabum 500 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, methioninum, aqua ad iniectabile q.s. ad solutionem pro 8 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Sotrovimabum	500mg / 8ml

Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Methionine
Polysorbatum 80
Saccharum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		PR	PR	A		Yes

2025	©ywesee GmbH